LIVN
LivaNova Plc
NASDAQ · Healthcare · Medical - Devices · GB
$78.14
+0.72%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$78.02
From 52W high−8.43%
Volume387098.00
Market cap$4.31B
P/E (TTM)22.6x
P/S (TTM)2.9x
Div yield—
Key dataOct 19, 2026
Open
$78.02
From 52W high
−8.43%
Volume
387098.00
Market cap
$4.31B
ValuationView details →
P/E (Fwd)
17.2x
EV/EBITDA
19.1x
P/E (TTM)
22.6x
RSI (14)
54.5
MomentumView details →
1D Return
+0.72%
YTD Return
+27.54%
SummaryUpdated Jun 1, 2026
LivaNova PLC (NASDAQ:LIVN) is a medical device company founded in 1987 and headquartered in London, United Kingdom. The company was created through the 2015 merger of Cyberonics and Sorin Group, combining expertise in neuromodulation and cardiac surgery technologies. LivaNova designs, develops, manufactures, and sells therapeutic solutions globally, focusing on three core segments: cardiopulmonary products for heart surgery, neuromodulation devices for neurological conditions, and advanced circulatory support systems. The company serves hospitals, medical institutions, and healthcare providers worldwide through direct sales representatives and independent distributors.
Similar companies
Latest newsMore news →
LivaNova PLC reported its second-quarter 2026 financial results, with revenue of $390.6 million, up 10.8% on a reported basis and 9.8% on a constant-currency basis year-over-year, and U.S. GAAP diluted EPS of $1.93.76d agoJette Nygaard-Andersen was elected to the Board of Directors of LivaNova PLC after its Annual General Meeting on June 10.131d ago